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Abstract
Background: Breast cancer is the second most common causes of women’s death, worldwide. Data on risk factors
associated with female breast cancer in the Afghan population is very limited. The aim of our study was to
identifying risk factor associated with female breast cancer in Afghanistan.
Methods: A retrospective case-control study was conducted with inclusion of 201 cases and 201 controls. Patient
information was collected by interviewing the patient through a structured questionnaire. Histopathological
information was collected from the hospital integrated laboratory management system. The data was analyzed by
using logistic regression with univariate and multivariable analyses to determine the association between breast
cancer and predictors.
Results: The results of the current study showed that factors such as: age (OR = 1.02; 95%CI: 0.99–1.04; p-0.148); age
at menarche (OR = 0.83; 95%CI: 0.72–0.92; p-0.008); age at first baby (OR = 1.14; 95%CI: 1.07–1.20; p- < 0.001); illiteracy
(OR = 1.93; 95%CI: 1.16–3.22; p-0.011); smoking (OR = 2.01; 95%CI: 1.01–3.99; p-0.04) and family history of cancer
(OR = 1.98; 95%CI: 1.18–3.32; p-0.009) were significantly associated with breast cancer. However, our study did not
demonstrate any statistically significant correlation between breast cancer and some of the predictors that were
previously highlighted in literature, such as: marital status, Body Mass Index (BMI), use of hormonal contraceptive,
breastfeeding and exercise.
Conclusion: Our study demonstrated that age at menarche, and age at first baby birth, illiteracy, smoking and
family history of cancer were significant risk factors associated with development of breast cancer among women
in Afghanistan. Health education of women regarding aforementioned predisposing factors are therefore, expected
to be valuable in decreasing the burden of breast cancer with reduction of its burden on the healthcare system in
Afghanistan.
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Background
Cancer is the world’s leading cause of mortality. World
Health Organization (WHO) reported that 7.6 million
people died of cancer in 2005 and it is predicted that 84
million people will die in the next 10 years [1]. Like
other malignant disorders, the genomic machinery that
directly regulates cellular proliferation, are affected dur-
ing the pathogenesis of breast cancer [2].
Breast cancer is a global health problem, affecting
breast parenchyma, with a global incidence of 1.7 million
new cases per year [3]. Constituting 23% of all cancers
around the world, breast cancer is the most common
malignancy in women, causing most of the cancer re-
lated death in women, being the second most common
cause of women death worldwide [4, 5]. According to
latest reports, breast cancer is a rapidly growing disease
in South America, Africa and Asia-pacific, thus warrant-
ing the need for early detection of breast cancer for re-
ducing the mortality [6]. Although the recent figures
from most of the Asian countries demonstrated that fe-
male breast cancer was the most common malignancy in
most of the Asian countries, still in some regions of the
developing world, it remains the second most common
malignancy followed by uterine cancer. Alarmingly,
around 60% of women’s death are due to breast cancer
in many of the developing countries [3]. On the other
hand, although, considering the available reports from
underdeveloped and developing countries in Asia, the
projected incidence of female breast cancer was lower if
compared to the Western countries, still the mortality
related to breast cancer was higher than the Western de-
veloped world [6]. The reason behind the higher mortal-
ity could be the scarce availability of modern diagnostic
as well as therapeutic interventional facilities in under-
developed and developing regions of Asia.
In Pakistan, the incidence of female breast cancer was
reported to be 50.1 per 100,000 making it the most com-
mon malignancy in Pakistani women [6]. Although inci-
dence rate of female breast cancer is not available for
whole Indian population, according to female breast
cancer registry, the incidence of breast cancer in three
important regions of India, that are Bombay, Bangalore
and Madras, was reported to be 25.6, 15.8 and 20.1, re-
spectively, per 100,000 female population, in 1985 [7]. In
Iran too, the female breast cancer ranked to be the first
and the most common malignancy among women, con-
stituting 21.4% of all female malignancies. Accordingly,
in Tehran alone, which is the capital city of Iran, female
breast cancer was one of the most common malignan-
cies in women compared to other malignancies with an
incident rate of 22.4 per 100,000 in 1998 [8]. While over
90% of symptomatic breast lesions are benign, breast
cancer constitutes a heterogeneous group of malignant
disorders with variable clinical features, histological
characteristics and variable therapeutic outcomes [9, 10].
Breast cancer is primarily classified on the basis of histo-
logical appearance, either into lesions that originate from
the ductal epithelium (inner lining) or the lobular epi-
thelium, which are the conduit of milk to ducts [11].
WHO has classified the breast cancers into 21 distinctive
histological types, based on cell morphology, growth and
architectural patterns [12]. The two most common
among all breast cancers are the Invasive Ductal Carcin-
oma (IDC) and Invasive Lobular Carcinoma (ILC), ac-
counting for up to 75 and 15%, of incidence, respectively
[13]. The remaining 10% of malignancies related to fe-
male breast include rare histologic types of mucinous,
metaplastic, inflammatory, medullary, and papillary car-
cinomas [14]. Worldwide, a large number of breast le-
sions are diagnosed due to widespread usage of
screening breast lesions by mammography and latest im-
aging technologies in the pre-clinical phase [15].
There are some established risk factors associated with
female breast cancer, which can be divided in two main
categories, i.e. non-modifiable risk factors including age,
sex, family history of breast cancer, proliferative breast
disease and the modifiable risk factors including expos-
ure to estrogen, weight, alcohol consumption, smoking,
physical activity, diet, anxiety and stress and exposure to
oral contraceptive [16].
According to the estimations by neighboring countries,
in Afghanistan, death due to cancer before the age of 75
years accounts for 11.4% of mortality in males and 10.2%
in females [17]. Considering the available data from
neighboring countries, although in Afghanistan the inci-
dence of breast cancer is not high, due to scarcity of ap-
propriate health services the mortality rate is reported to
be equal to or even more than Western countries [18].
There is a scarcity of research regarding breast cancer in
Afghanistan and the available estimates are mostly
dependent on data generated from neighboring countries.
We conduct this study to estimate the risk factors associ-
ated with breast cancer in Afghan female population.
Methods
Study design
For this research, a retrospective case-control study de-
sign was used. This study compared the female breast
cancer (outcome of interest, cases) with non-breast can-
cer (controls), and observed the association of potential
risk factors present in each group.
Study population
The study population consisted of 201 women with
breast cancer aged 30 years and older, paired by age, ad-
mitted between January 2018 to December 2019, at
French Medical Institute for Mothers and Children
(FMIC) and Jamhoriat Tertiary Care Hospital (JTCH),
Baset et al. BMC Cancer           (2021) 21:71 Page 2 of 9
two of the reference institutions for histopathology and
oncology in Kabul, Afghanistan. Out of 201 cases of
breast cancer, 178 cases were invasive ducal carcinoma,
6 cases were invasive lobular carcinoma, 4 cases were
medullary carcinoma, 1 case was metaplastic carcinoma
and 12 cases was other malignant breast cancer.
Sample size
For sample size calculation we used OpenEpi (open
source epidemiologic statistics for public health) statis-
tical software. Taking the confidence interval of 95%,
power of the study 80% and case and control ratio as (1:
1) by taking odds ratio of 2.78 of parity the minimum
sample size for case and control was calculated 382 [19].
Taking non-respondents, errors, withdrawal and missing
data into consideration, the total sample size has been
inflated by 5%, the final sample size calculated 201 case
and 201 controls.
Selection of cases and controls
Cases were defined as female participants with breast
cancer diagnosed by histopathologic examination and
age ≥ 30 years. The control group included the women
without breast cancer with the same age of the case. The
controls were recruited from the same hospital and were
confirmed for the disease status by the same histopatho-
logical examination as for cases.
Data collection
All cases were collected mainly from department of on-
cology, JTCH and form Integrated Laboratory Manage-
ment System (ILMS) of FMIC. A pre-test was done
before collection of the data. Patients were called to fill
the questionnaire on the day of collecting the report. A
written consent was taken from patients. The interview
was conducted mainly by the female co-investigator. All
items included in the questionnaire had short answer or
were single choice questions. Data for control group was
collected randomly from department of obstetrics &
gynecology, FMIC, department of pathology & clinical
laboratory and Isteqlal tertiary care hospital (ITCH)
from those patients who were admitted with no history
of breast neoplastic disease.
Data collection tool
Data was collected using the tool developed by the
principle investigator. The tool was developed in English
language and translated to the local Farsi/Dari language.
Before using the tool, it was sent to five experts to check
the clarity, relevance and context of the tool on scale of
1–4. The content validity index for clarity and relevance
was calculated, which was found to be 0.92 and 0.94, re-
spectively. For estimation of the reliability of the study,
Cronbach alpha test was conducted, the result was 0.83.
The tool was pretest upon 10% of population, some
changes were made based on pretesting results. Pretest
data was not included in the study. Each interview was
taken in a comfortable place and lasted for15–20 min in
Isteqlal hospital, the data was collected by a female data
collector who was well trained by the principle investiga-
tor. Whereas, in other centers (FMIC, JTCH), data were
collected by the principal investigator. Variables such as
use of oral contraceptive, history of breast feeding,
smoking, BMI, exercise, educational status, age, preg-
nancy history, family history of cancer, age at menarche,
marital status were assessed with the help of a
questionnaire.
Data management and quality control
In order to ensure quality of data collection, the data
collector was properly trained by principal investigator.
However, the questionnaire was self-administered tool
but data was collected by interview to help reduce er-
rors. For first few days the data collector had collected
data under the supervision of the principal investigator
to fully and accurately understand the process of data
collection. Field editing and office editing was done by
the principle investigator to identify any missing or
wrong entries on daily basis. Data was entered into Stat-
istical Package for Social Sciences (SPSS, version 25.0)
by double entry strategy. Hard copy of data was kept
under lock and key and soft copy of data was kept on
password protected personal computer to which only
principle investigator had access. The data has been
already shared with committee members.
Data analysis
Mean and standard deviation (SD) were estimated for
continuous/discrete variables. For categorical variables,
frequency and proportions were calculated. Logistic re-
gression was applied to measure the association amongst
independent variables and dependent variables. The lo-
gistic regression was carried out in two steps. In the first
step association between breast cancer and each inde-
pendent variable was examined while the dependent
variable and the odds ratios were estimated. In the sec-
ond step, all the variables which were found significant
at the univariate level (p-value ≤0.25), were considered
for multivariable model. The multivariate analysis of risk
factors was calculated through enter method for the
construction of model and controlling the confounders
in the study. Odds ratio (OR) and 95% Confidence Inter-
val (CI) were reported to determine the association be-
tween breast cancer and risk factors.
Results
The descriptive statistics for case and control as con-
tinuous variable are listed in Table 1. Similarly, the
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descriptive statistics for categorical variables are shown
in Table 2.
Descriptive statistics of continuous variables
Table 1 describes the distribution of continuous vari-
ables of age, Body Mass Index (BMI), age at first baby
and age at menarche for both cases and controls. The
age of the participants was ≥30 (measured in years). The
mean age (±SD) for cases and controls was 45.8 (±10.5)
and 41.7 (±10.14), respectively. However, the mean BMI
for cases was 26.3 (±5.3), while for controls it was 26.7
(±5.3). The mean age at first baby’s birth in cases was
23.1 (±5.3) while the mean age at first baby for controls
was 20.7 (±3.9). Among cases, the mean age at menarche
was 13.3 (±2.1) and for control it was 13.9 (±1.65).
Descriptive statistic of cases and controls on categorical
variables
Table 2 explains the descriptive statistics on categorical
variables. Among cases, 121 (60.2%) were illiterate
whereas 89 (44.3%) of the controls were illiterate. 176
(87.6%) women from cases were married, while 174
(86.6%) women from controls were married. Family his-
tory of cancer was present in 57.2% of case and in 76.1%
of control groups. Out of 201 cases, 150 (74.6%) breastfeed
their children, while 149 (74.1%) of the controls had his-
tory of breastfeeding. The use of contraceptive was similar
in both cases and controls 56 (27.9%). In cases, 45 (22.4%)
were smokers, the frequency of smoking among controls
was 23 (11.4%). Only 42 (20.9%) women from case group
were physically active and doing regular exercise, while it
was 47 (23.4%) in control group women.
Test statistics for normality check of continuous variables
Table 3, after descriptive statistics, we evaluated the nor-
mality for continuous variables. There were four con-
tinuous variables in this dataset. Since the sample size is
more than 50, so we looked for Kolmogorov-Smirnov in-
stead of Shapiro test. Initially we looked at histograms,
the graphical representation showed the variables are
not symmetrical. Then we looked at the p-values of
Kolmogorov-Smirnov test. Since p-values were less than
alpha so we reject null hypothesis and conclude that the
data is not normally distributed.
Logistic regression
Inferential statistics, i.e. logistic regression, was applied
to identify the association among dependent variables
and independent variables. Logistic regression is consid-
ered the best for describing the association between a
categorical dependent variable and one or more continu-
ous or categorical independent variables. The logistic
Table 2 Descriptive statistics of breast cancer cases (n = 201)
and controls (n = 201) in Afghanistan for categorical variables
Variables Cases (n = 201)
n %
Controls (n = 201)
n %
Educational status
Illiterate 121 60.2 89 44.3
Literate 80 39.8 112 55.7
Marital status
Single 25 12.4 27 13.4
Married 176 87.6 174 86.6
Family history of breast cancer
No 115 57.2 153 76.1
Yes 86 42.8 48 23.9
History of pregnancy
Yes 163 81.1 161 80.1
No 38 18.9 40 19.9
History of contraceptive use
No 145 72.1 145 72.1
Yes 56 27.9 56 27.9
History of breast feeding
Yes 150 74.6 149 74.1
No 51 25.4 52 25.9
Exercise
No 159 79.1 154 76.6
Yes 42 20.9 47 23.4
Smoking status
No 156 77.6 178 88.6
Yes 45 22.4 23 11.4
Table 3 Test statistics for normality check of continuous
variables
Variables Test statistics p-value
Age 0.134 < 0.001
Age at the first baby 0.118 < 0.001
Age at menarche 0.144 < 0.001
BMIa 0.064 0.003
aBMI Body Mass Index
Table 1 Descriptive statistics of breast cancer cases (n = 201)
and controls (n = 201) in Afghanistan for continuous variables
Cases (n = 201) Controls (n = 201)
Variables Mean (SD a) Mean (SD)
Age in years 45.8 (10.5) 41.7 (10.1)
BMI a 26.3 (5.3) 26.7 (5.3)
Age at first baby birth 23.1 (5.3) 20.7 (3.9)
Age at menarche 13.3 (2.1) 13.9 (1.6)
aSD Standard Deviation, BMI Body Mass Index
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regression was carried out in two steps. In the first
step association between each independent variable
was examined with the dependent variable and the
odds ratios and their 95% CI were computed. All the
variables which were found significant at the univari-
ate level (p-value≤0.25), were considered for multivar-
iable model.
Univariate analysis
The unadjusted OR and their 95% CIs are reported in
Table 4. The variables which were found to be signifi-
cant were age, age at first period, age at first baby birth,
education, family history of breast cancer, and smoking
status. The other variables which were added in logistic
regression model at univariate level were marital status,
BMI, history of pregnancy, history of contraceptive, sta-
tus of breast feeding and exercise did not show signifi-
cant association.
The patient age was found to be significantly associ-
ated with breast cancer. With one-unit increase in age,
the risk of breast cancer also increased as evident by
(OR = 1.04, 95% CI: 1.02–1.06, p-value< 0.001). More-
over, an association between level of education and
breast cancer was also statistically significant (p-value<
0.001). The risk of breast cancer was found to be 1.9
times to the risk of breast cancer among illiterate cohort
(OR = 1.9, 95%CI: 1.28–2.83). Age at first period was also
significantly associated with breast cancer. It was ob-
served that with 0.85-fold decrease in age at menarche,
the risk of cancer is also decreasing (OR = 0.85, 95%CI:
0.76–0.95, p-value = 0.003).
Likewise, a significant association was also observed
between smoking and breast cancer (p-value = 0.004);
among the participants who were active smoker the risk
of breast cancer is 2.23 times more than non-smokers
(OR = 2.23, 95% CI: 1.29–3.9, p-value = 0.004). Like
smoking, family history of cancer was significantly asso-
ciated with breast cancer, it suggests those who has fam-
ily history of cancer are 2.38 times more prone to breast
cancer; as compared to those who have no family history
of cancer (OR = 2.38, 95%CI: 1.55–3.65, p-value< 0.001).
Furthermore, the age at first baby birth is significantly
associated with breast cancer, it showed that by one-year
increase in age the risk of breast cancer also increases
(OR = 1.12, 95%CI: 1.06–1.18, p-value< 0.001).
Multivariate analysis
As illustrated in Table 5, the multi-variable model in-
cludes five variables which came out to have significant
association at the multivariate level (p-value< 0.05). The
Table 4 Univariate logistic regression of socio-demographic
and potential risk factors associated with breast cancer in
Afghanistan (n = 402)
Variables UAOa 95% C.I p- value
Age 1.04 (1.02–1.06) < 0.001
Educational Status




Married 0.92 (0.51–1.64) 0.77
BMIa 0.98 (0.95–1.02) 0.38
Family history of breast cancer
Yes 1
No 2.38 (1.55–3.65) < 0.001
History of pregnancy
Yes 1
No 0.94 (0.57–1.54) 0.801
Age at first period 0.85 (0.76–0.95) 0.003
Age at first baby birth 1.12 (1.06–1.18) < 0.001
Use of contraceptive
Yes 1
No 1.000 (0.65–1.55) 1.000
Status of breast feeding
Yes 1
No 0.97 (0.62–1.53) 0.909
Exercise




No 2.23 (1.29–3.9) 0.004
aUOR Unadjusted Odds Ratio, BMI Body Mass Index
Table 5 Multivariate logistic regression for risk factors
associated with breast cancer in Afghanistan (n = 402)
Characteristics AORa 95% CI p-value
Age 1.02 (0.99–1.04) 0.148
Age at menarche 0.83 (0.72–0.92) 0.008
Age at first baby birth (in year) 1.14 (1.07–1.20) < 0.001
Educational Status




No 2.01 (1.01–3.99) 0.04
Family history of breast cancer
Yes 1
No 1.98 (1.18–3.32) 0.009
aAOR Adjusted Odds Ratio
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final model, variable such as age at first period, age at
first baby birth, education level, smoking and family his-
tory of breast cancer found to have statistically signifi-
cant association with female breast cancer. However,
variables such as marital status, BMI, history of preg-
nancy, contraceptive, breast feeding and exercise were
not statistically significant with female breast cancer.
Age which was significantly associated (p-value< 0.001)
with breast cancer in univariate level; however, it is not
significant in multivariate analysis (p-value = 0.148). Age
at first period (menarche) is significantly associated with
breast cancer (OR = 0.83, 95% CI: 0.99–1.04, p-value
0.008). As age at first period increases the odds of breast
cancer was 0.83 times; conversely, with increase in age
at first baby birth, the risk of breast cancer increases
(OR = 1.14, 95%CI: 1.07–1.20, p-value< 0.001).
Family history of cancer was found to be an im-
portant risk factor for breast cancer. The odds of hav-
ing a family history of breast cancer is 2.2 times
higher among cases as compared to controls (OR =
2.2, 95% CI: 1.4–3.5). Similarly, smoking was found to
be a risk factor for developing breast cancer as evi-
dent by (OR = 2.01, 95% CI: 1.01–3.99). Likewise, edu-
cation level was found to be a significant factor for
case. The odds of being illiterate was 1.93 in cases as
compared to odds of being illiterate among controls
(OR = 1.93, 95%CI: 1.16–3.22, p-value = 0.011).
Model fitness and significance
The findings of the multivariate analysis found overall
model found to be significant as evident by significant
p-value of less than 0.001 in omnibus test of model
coefficient. We have sufficient evidence to conclude
that age, age at first baby, age at menarche, illiteracy,
smoking status and family history of breast cancer
were statistically associated with breast cancer in
multivariate adjusted model. Finally, the model ex-
plained 21.6% of the variability in breast cancer is ex-
plained by all the independent variables present in
final model as evident by Nagelkerke R square value.
Goodness for fit test, the Hosmer and Lemeshow test
statistics was 8.375 with p-value of 0.398 which shows
that fail to reject null hypothesis and conclude that
the model was well fit to the data.
Discussion
The study aimed to identify the factors associated with
development of female breast cancer among Afghan
population. The current research demonstrated a signifi-
cant association between age, age at menarche, age at
first baby birth, illiteracy, smoking and family history of
cancer with breast cancer among females in Afghanistan.
The study did not reveal any statistically significant asso-
ciations between breast cancer and previously
highlighted predictors of the disease, such as: marital
status, BMI, use of hormonal contraceptive, breastfeed-
ing and exercise, probably due to sampling error and
low power of the research.
Age was not significantly associated with breast can-
cer, when considering multivariate model but due to
clinical significance we preserved this variable in the
final model. Univariate analysis revealed that as age in-
creased by one unit (year), the risk of breast cancer also
increased. The findings of our study were comparable
with the previous studies. As the patient age increased,
the incidence of breast cancer increased. Younger age at
the time of diagnosis was linked with high mortality
[20]. A study conducted in Poland demonstrated find-
ings that were similar to our study. They reported that
breast cancer was frequently diagnosed around meno-
pause and significantly less common below the age of
45 years [21]. Similarly a study conducted by Helena D
et al., demonstrated that age had significant association
with development of breast cancer [22]. As the women
age, damages occur to the ductal epithelial cells of mam-
mary glands, thus increasing the chance for neoplastic
transformation. The plausible reason for this relationship
could be a prolonged exposure to estrogen which is an
independent risk factor for breast cancer development;
furthermore, with aging, depending on lifestyle, the pos-
sibility of sustaining cellular damage via exposure to ra-
diation and other environmental oncogenic risk factors
can also be deemed accountable to affect the genomic
machinery [23].
The current study revealed a significant association be-
tween early age at menarche and development of breast
cancer. As age at first period increased, the risk of breast
cancer development was shown to reduce by 0.83 times.
These findings were consistent to the findings of a study
conducted by Monteiro DLM et al., reported that early
menarche was a strong risk factor for breast cancer [24].
Similarly, in another study, a strong association was
demonstrated between early age at menarche and ILC of
breast [25]. Data from the study conducted by Bhupathi
S et al. also suggested that there was a significant associ-
ation between early age at first menarche and breast
cancer [19]. Furthermore, a study conducted in Morocco
revealed a significant association of early menarche with
breast cancer in univariate level of logistic regression
analysis [26]. Estrogen and progesterone are the hor-
mones produced by ovaries and it was frequently re-
ported that these hormones were stimulators for breast
cancer; in early menarche, women are exposed earlier to
these two hormones, thus, the risk of breast cancer in-
creases [27]. It was also reported that early menarche
was associated with ILC of breast which are estrogen re-
ceptor positive tumors [27, 28]. Surprisingly, a study
conducted in Turkey demonstrated no correlation of
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statistical significance between early menarche and
breast cancer [29]. On the contrary, there were no avail-
able data in the literature that would show a negative
association between early age at menarche and develop-
ment of breast cancer.
The present study suggested that late age at first
baby born was a risk factor for developing breast
cancers. As the age at birth of first baby increased,
the risk of breast cancer also increased by 1.14 times
per year. Monteiro DLM et al. also demonstrated that
age at first pregnancy was significantly associated
with development of breast cancer [24]. Another
study demonstrated that first pregnancy after age 35
increased the risk of breast cancer [30]. The possible
reason could be the activation of JAK-STAT5 signal-
ing pathway which in its activated form, the pSTAT5
has been proven to be a pro-survival promotor pro-
tein for ductal cells. The mentioned activated protein
increases during pregnancy and lactation, thus, those
proteins protect the ductal cells from mutations. It
has been shown that during pregnancy breast cells
multiply less, leading to lesser development of tumor
which could be a protective factor. The reason be-
hind increased risk of breast cancer with first preg-
nancy at age 35 may be breast tissue which are
responsible of carrying cluster of cells with cancer
causing mutation [30].
The literacy was associated with breast cancer in the
current study. A study conducted in Iran on population
of 1,477,045, also had similar findings, in which, out of
770 women who had breast cancer 287 (37.3%) were
illiterate [31]. A study done in Bangui of Central Africa
showed that lack of education was significantly associ-
ated with breast cancer (p-value< 0.001) [32]. Literacy
was a protective factor for breast cancer according to
Harirchi I et al. [31].
The present study provided an evidence of a signifi-
cant association between smoking and development of
breast cancer where the smokers were 2.01 times
more prone to developed breast cancer as compared
to control group. Consistent with current study, a re-
search done by Catsburg C et al. depicted a strong
association between smoking and breast cancer [33].
Moreover, most of literature linked smoking with
higher risk of breast cancer [34]. Furthermore, a study
showed significant association between smoking and
breast cancer, in those female who do not used alco-
hol [35]. As per our observation, chillum (pipe smok-
ing) is very common among women in Afghanistan.
The most probable reason could be the uptake of to-
bacco carcinogens by breast ductal cells including N-
nitrosamines, polycyclic aromatic hydrocarbons and
aromatic amines, that are mostly involved in mutation
of p53 gene [34].
The findings of our study showed that positive family
history of cancer was significantly associated with breast
cancer, with the odds of having a positive family history
of cancer being 2.2 times higher among cases as com-
pared to controls, which was similar with the findings of
a study done by Laamiri FZ et al. who demonstrated that
positive family history in immediate relatives was signifi-
cantly associated with breast cancer, however, they
didn’t report any association between breast cancer and
positive family history in second degree relatives [26].
Likewise, in another study conducted in Iraq, the Iraqi
patients who developed breast cancer had 30% positive
family history of cancer. Among those, 18.5% had family
history of breast cancer [36].
Similar to our study, a previous study conducted in
Central Africa found that positive family history was a
strong risk factor for developing of breast cancer [32].
The major reason behind this association might be
inherited gene mutation such as Breast Cancer Gene 1
(BRCA1) or Breast Cancer Gene 2 (BRCA2) mutations.
On the other hand, some literature also suggested the
checkpoint kinase 2 (CHEK2, Chk2) gene role for devel-
oping breast cancer [37, 38]. Contrary to the findings of
the present study, Monteiro DLM et al. reported no rela-
tionship between positive family history of cancer, use of
hormonal contraceptive, use of alcohol, ethnicity, to-
bacco, and breast cancer [24].
Our study was conducted in multiple tertiary care hospi-
tals which increased the probability of representing Afgha-
nistan’s whole population. This research was made with an
effort to identify potential confounding factors and the
sample size was adequately powered to adjust the effect of
confounders while investigating the objectives of the study.
On the contrary, it was a hospital based case-control study
which limited the generalizability of the results only to pa-
tients visiting hospitals. We measured BMI at the time of
calling patient for research. Although, BMI at time of pres-
entation of disease does not always correlate with BMI
after treatment. As case-control study design was imple-
mented for this study, the responses were based on self-
reported measures that can possibly lead to the presence
of recall bias. This study provided evidence about the po-
tential risk factors of breast cancer, especially considering
Afghan women. Here is a dire need to conduct multi-
center longitudinal cohort studies to explore temporal re-
lationship between various factors and breast cancer.
Conclusion
This study demonstrated that age, age at menarche, age
at first baby’s birth, illiteracy, smoking and family history
of cancer were the positive predictors of developing
breast cancer among women in Afghanistan. Attempts
should be made to educate women regarding the risk
factors associated with development of breast cancers, in
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an attempt to reduce the prevalence and thus decrease
the burden of breast cancer and its impact on the
healthcare system in Afghanistan. It is needed that the
data system in the hospitals of country must be im-
proved so that these type of data are recorded at time of
admission of patients.
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